Blue Jet Health
Biotechnology · BLUEJET
Mid CapHealthcareHigh Growth
Shiven Akshay Arora
Managing Director · Pragmatic
Company DNA
Founder-Centric
About
Blue Jet Health is a Mid Cap company in the Healthcare sector, listed on NSE as BLUEJET. With a market cap of ₹7K Cr and revenue of ₹1K Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. High promoter holding with a strong founder-family involvement in strategic vision and business operations. Its strategic mandate: As a specialized CDMO player, it needs to capture global market share by scaling high-barrier manufacturing capabilities.
FAQ
What kind of company is Blue Jet Health?
Blue Jet Health is a Mid Cap Healthcare company (BLUEJET) in the High Growth phase with a market cap of ₹7K Cr. It is classified as Founder-Centric in culture.
What is Blue Jet Health's culture and work environment like?
Blue Jet Health has a Founder-Centric culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. High promoter holding with a strong founder-family involvement in strategic vision and business operations.
Who leads Blue Jet Health?
Blue Jet Health is led by Shiven Akshay Arora (Managing Director), a Pragmatic leader with 10 years of experience.
What are Blue Jet Health's financials?
Blue Jet Health reported revenue of ₹1K Cr in FY25 with a 5-year revenue CAGR of 14.8%. Operating margin: 35.1%. Market cap: ₹7K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTechnical-Expert
LifecycleHigh Growth
High promoter holding with a strong founder-family involvement in strategic vision and business operations.
Mandate
As a specialized CDMO player, it needs to capture global market share by scaling high-barrier manufacturing capabilities.
As a specialized CDMO player, it needs to capture global market share by scaling high-barrier manufacturing capabilities.
Financials
Revenue FY25₹1K Cr
PAT FY25₹305 Cr
Rev CAGR 5Y14.8%
OPM35.1%
NPM29.7%
ROE26.9%
ROCE31%
P/E21.2
Fwd P/E19.9
P/B4.9
D/E1.6
Mkt Cap₹7K Cr
Promoter79.8%
Institutional2.2%
Similar Culture
Could You Lead Blue Jet Health?
Take the Genome Benchmark →